J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action ...

Here, a large proportion of studies show that probiotics in particular may have a positive effect, either by reducing ...

Khaberni - A large-scale medical study conducted in Taiwan has revealed a correlation between the use of assisted ...

If you experience chronic dry, itchy and red skin, you may be one of the millions of Americans with eczema. The National Eczema Association reports that an estimated 10% of the world population ...

Johnson & Johnson has discontinued a phase 2 trial of one of its pipeline candidates for atopic dermatitis (AD), after it ...

Collaborating institutions in Taiwan report higher risks of atopic disease among children conceived via assisted reproductive ...

HealthDay News — Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study published online Nov. 27 in Nutrients.

Experts break down the most important facts about atopic dermatitis on the hands, including risk factors, treatments, and tips for soothing relief. Atopic dermatitis (AD), the most common form of ...

Please provide your email address to receive an email when new articles are posted on . 40% to 50% of patients with chronic hand eczema have concomitant atopic dermatitis. Differentially expressed ...

Johnson & Johnson and Genmab both used the festive period to junk therapies that haven’t lived up to their promise in the ...